Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents.

Currently, the clinical use of 5-aminolaevulinic acid (ALA)-induced protoporphyrin IX (PPIX) for photodynamic therapy (PDT) is limited by the maximum tolerated oral ALA dose (60 mg kg(-1)). This study investigates whether hydroxypyridinone iron-chelating agents can be used to enhance the tissue leve...

Descripción completa

Detalles Bibliográficos
Autores principales: Curnow, A., McIlroy, B. W., Postle-Hacon, M. J., Porter, J. B., MacRobert, A. J., Bown, S. G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063198/
https://www.ncbi.nlm.nih.gov/pubmed/9823966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063198/
https://www.ncbi.nlm.nih.gov/pubmed/9823966

Ejemplares similares